Heart Disease News and Research

Latest Heart Disease News and Research

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

Researchers assessed the impact of bebtelovimab (BEB) monoclonal antibody in the treatment of high-risk SARS-CoV-2 Omicron variant-infected patients.

13 Dec 2022

Study identifies factors linked to well-being as people age

What are the keys to "successful" or optimal aging? A new study followed more than 7000 middle-aged and older Canadians for approximately three years to identify the factors linked to well-being as we age.

13 Dec 2022

Are you an optimist? Could you learn to be? Your health may depend on it.

When you think about the future, do you expect good or bad things to happen? If you weigh in on the "good" side, you're an optimist. And that has positive implications for your health in later life.

13 Dec 2022

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Researchers from The University of Texas MD Anderson Cancer Center are presenting compelling findings from three clinical trials at the 2022 American Society of Hematology Annual Meeting.

13 Dec 2022

Study discovers link between a lesser-known hormone and lipid levels in midlife women

Step aside estrogen. Scientists at the University of Pittsburgh have discovered a predictor of blood lipid - or cholesterol - status for midlife women that may be key to understanding how hormone replacement therapy contributes to heart health.

12 Dec 2022

Individuals with depression less likely to adhere to medications following percutaneous coronary intervention

Patients diagnosed with depression were less likely to adhere to essential medical therapies following percutaneous coronary intervention (PCI) than those without depression, according to a new study published in JAMA Network Open by researchers at the University of Pittsburgh School of Medicine.

12 Dec 2022

COVID-19 vaccination temporarily alters heart rate variability

HRV parameters after COVID-19 vaccination show significant short-term changes that may persist for up to three days until ultimately returning to baseline.

12 Dec 2022

Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

Investigators from the Smidt Heart Institute at Cedars-Sinai validated the link between a debilitating heart condition and COVID-19 and, to a lesser extent, a novel link between the same condition and COVID-19 vaccination.

12 Dec 2022

Novel wearable device can monitor physiological parameters associated with heart failure in real-time

There are about 64 million cases of heart failure worldwide. According to the American Heart Association, 6.2 million adults in the United States have heart failure and that number is estimated to increase to 8 million by 2030.

12 Dec 2022

Exposure to extremely hot or cold temperatures increases heart disease deaths

Exposure to extremely hot or cold temperatures increases a heart disease patient's risk of dying, according to a new study published today in the American Heart Association's journal Circulation.

12 Dec 2022

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab - a novel, patient-tailored monoclonal antibody therapy - showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

$Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction$

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF) >40%, including HF with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF).

From AstraZeneca 12 Dec 2022

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

For people ages 75 and older, age-related changes in general health and in the heart and blood vessels require consideration and likely modifications in how heart attacks and heart disease are treated, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

12 Dec 2022

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

A new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73 percent of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

12 Dec 2022

A-HIPI decision model can predict survival in adults with advanced-stage Hodgkin lymphoma

Investigators from Rutgers Cancer Institute of New Jersey, the state's only NCI-designated Comprehensive Cancer Center and leading cancer program along with Tufts Medical Center in Boston, developed and validated the Advanced-stage Hodgkin lymphoma International Prognostication Index (A-HIPI).

12 Dec 2022

Complementary, alternative therapies for heart failure have some benefits and potential risks

There are some benefits and potentially serious risks when people with heart failure use complementary and alternative medicines (CAM), to manage symptoms, so involving the health care team is important for safety, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Dec 2022

One-minute bursts of activity during daily tasks associated with reduction in risk of premature death

In good news for those who don't like playing sport or going to the gym, new research finds just three to four one-minute bursts of huffing and puffing during daily tasks is associated with large reductions in the risk of premature death, particularly from cardiovascular disease.

8 Dec 2022

Researchers receive $11 million NIH grant to evaluate a 5-minute dementia screening tool

Investigators at Albert Einstein College of Medicine, Montefiore Health System, Regenstrief Institute, and Indiana University School of Medicine have received an $11 million grant from the National Institutes of Health to evaluate an Einstein-developed test for assessing cognitive impairment and dementia.

8 Dec 2022

Addition of yoga to regular exercise training supports cardiovascular health and wellbeing

A three-month pilot study of patients with hypertension appearing in the Canadian Journal of Cardiology, published by Elsevier, demonstrates that adding yoga to a regular exercise training regimen supports cardiovascular health and wellbeing and is more effective than stretching exercises.

8 Dec 2022

New 'heart attack on a chip' could serve as a testbed to develop personalized medicines

Researchers at the University of Southern California Alfred E. Mann Department of Biomedical Engineering have developed a "heart attack on a chip," a device that could one day serve as a testbed to develop new heart drugs and even personalized medicines.

7 Dec 2022

Heart Disease News and Research

Latest Heart Disease News and Research

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

Study identifies factors linked to well-being as people age

Are you an optimist? Could you learn to be? Your health may depend on it.

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Study discovers link between a lesser-known hormone and lipid levels in midlife women

Individuals with depression less likely to adhere to medications following percutaneous coronary intervention

COVID-19 vaccination temporarily alters heart rate variability

Researchers show link between a debilitating heart condition and COVID-19 infection, vaccination

Novel wearable device can monitor physiological parameters associated with heart failure in real-time

Exposure to extremely hot or cold temperatures increases heart disease deaths

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Forxiga (dapagliflozin) approved in Great Britain for symptomatic chronic heat failure across the full spectrum of left ventricular ejection fraction

Aging influences the diagnosis and treatment of heart attacks in patients over age 75

Off-the-shelf immunotherapy could offer new hope for patients with hard-to-treat multiple myeloma

A-HIPI decision model can predict survival in adults with advanced-stage Hodgkin lymphoma

Complementary, alternative therapies for heart failure have some benefits and potential risks

One-minute bursts of activity during daily tasks associated with reduction in risk of premature death

Researchers receive $11 million NIH grant to evaluate a 5-minute dementia screening tool

Addition of yoga to regular exercise training supports cardiovascular health and wellbeing

New 'heart attack on a chip' could serve as a testbed to develop personalized medicines

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Heart Disease News and Research

Latest Heart Disease News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in